DIN 02505517 — BIVALIRUDIN INJECTION 5 MG
BIVALIRUDIN INJECTION is a solution of Bivalirudin marketed by AVIR PHARMA INC.. The full Bivalirudin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02505517
- Brand name
- BIVALIRUDIN INJECTION
- Active ingredient
- Bivalirudin
- Strength
- 5 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- AVIR PHARMA INC.
- Health Canada status
- MARKETED
- Drug class
- Direct thrombin inhibitor (anticoagulant)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Bivalirudin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02246533 | ANGIOMAX | 250 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02435268 | BIVALIRUDIN FOR INJECTION | 250 MG | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02511452 | BIVALIRUDIN FOR INJECTION | 250 MG | POWDER FOR SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED |
| 02539586 | BIVALIRUDIN FOR INJECTION | 250 MG | POWDER FOR SOLUTION | FORMATIVE PHARMA INC. | MARKETED |